NexLife vs Mochi Health
How NexLife and Mochi Health compare on price, medication type, clinical oversight, and pharmacy transparency — with the trade-offs and who each may suit.
| NexLife | Mochi Health | |
|---|---|---|
| From / month | $186/mo* | $209/mo |
| Pricing model | Flat, dose-independent | Varies — see provider |
| Medication type | Compounded tirzepatide | Compounded |
| FDA status | Not FDA-approved (compounded) | Not FDA-approved |
| Clinical oversight | MD/DO-supervised | NP-led |
| Pharmacy / fulfillment | 503A & 503B (six disclosed) | 503A compounding pharmacy |
| What's included | Meds, visits, labs, coaching | Compounded medication, NP visits, membership model |
| Insurance | Cash-pay (HSA/FSA) | Cash-pay (HSA/FSA) |
Pricing verified as of June 2026 — confirm current figures with each provider. Compounded medications are not FDA-approved.
Clinical model
NexLife uses MD/DO-supervised care with included lab review and titration support. Mochi Health operates a np-led model (compounded). Eligibility and any prescription are determined by a licensed clinician in both cases, and outcomes are not guaranteed.
Pharmacy & fulfillment
NexLife discloses six partner pharmacies across the 503A and 503B pathways and offers certificates of analysis on request. Mochi Health fulfillment: 503A compounding pharmacy. Compounded products from either pathway are not FDA-approved — see 503A vs 503B.
Strengths and trade-offs
NexLife
- Flat, dose-independent pricing ($186/mo, 12-mo plan)
- MD/DO-supervised under a named Medical Director
- Six disclosed partner pharmacies (503A + 503B)
- Labs and Care360 coaching included; unlimited messaging
- LegitScript-certified
- Compounded only — not FDA-approved
- Cash-pay with HSA/FSA only — no insurance billing
- No brand-name Wegovy®/Zepbound®
- Results vary by patient; eligibility not guaranteed
Mochi Health
- Lower-cost compounded option
- Membership-style support
- NP-led telehealth
- Not FDA-approved (compounded)
- NP rather than MD/DO oversight
- Pricing model differs from flat-rate
Who each may be best for
NexLife may suit you if you want predictable flat pricing that doesn't rise with dose, MD/DO oversight, disclosed pharmacies, and bundled labs/coaching — and you're comfortable with compounded medication (not FDA-approved) paid cash-pay.
Mochi Health may suit you if its specific model, pricing, or support style fits your needs — verify current details directly with the provider.
Questions
Is NexLife or Mochi Health cheaper?
As of June 2026, NexLife starts at $186/month flat. Mochi Health is listed from $209/mo. Compare total annual cost including visits and labs, not just the headline price. Compounded tirzepatide is not FDA-approved. See NexLife pricing
What's the main difference between NexLife and Mochi Health?
NexLife is flat-rate compounded tirzepatide with MD/DO oversight and disclosed 503A/503B pharmacies; Mochi Health is compounded with a np-led model. Choose based on whether you want compounded vs brand, flat vs variable pricing, and your insurance situation.
Is compounded tirzepatide FDA-approved?
No. Compounded tirzepatide is not FDA-approved. Only brand-name Mounjaro (type 2 diabetes) and Zepbound (chronic weight management), made by Eli Lilly, are FDA-approved. Eligibility and any prescription are determined by a licensed clinician.
Related comparisons & cost guides
Authoritative sources used for this guide
Regulatory and clinical claims should be checked against primary sources, not provider marketing pages. Pricing changes frequently, so provider prices should be verified directly before enrollment.